BUSINESS
Vijaya Diagnostic: Healthy show continues
The management reiterated its guidance of achieving a top-line growth of around 15 percent and maintaining the current margin profile in FY26.
BUSINESS
Brigade Hotel Ventures: Does the IPO offer a good investment opportunity?
The hotelier’s return ratios are solid and the stock valuation is attractive while part of the IPO money will support growth plans
BUSINESS
Should you decorate your portfolio with this auto ancillary stock?
Driven by the growing demand for aesthetics in premium vehicles, SJS expects to grow at 2x the industry volume in FY26.
BUSINESS
Gabriel India: Unlocking new doors of opportunities
The company recently announced a demerger scheme. This move will transform Gabriel from a single product company into a highly diversified mobility solutions provider.
BUSINESS
Is this agrochemical IPO a good bet?
The company plans to invest in a new dry flowable manufacturing plant to add newer formulations in its portfolio.
BUSINESS
Optimism low on this healthcare stock
Medanta has strong capabilities to leverage its brand image. However, near-term growth looks limited
BUSINESS
How is the health of this healthcare stock?
Timely execution and ramp-up of new projects are crucial for faster growth
BUSINESS
This hospital chain is aiming for high growth, but is it already priced in?
Max is on an aggressive expansion path with healthy medium-term growth visibility
BUSINESS
Apollo Hospitals: Annual report card ticks all the right boxes
Robust expansion plans in place with the target to add a total of about 4000 beds in the next 3-4 years
BUSINESS
Fiem Industries Q4 FY25: Sturdy results with a healthy outlook
The company is foraying into the PV segment while exploring opportunities in the EV market
BUSINESS
Rallis India: Stars align in Q2, what does its pitch report say?
The company is focusing on optimising portfolio and streamlining capacities
BUSINESS
Krsnaa Diagnostics: Creating new opportunities for itself
With the ramp-up of new projects and fresh order wins, the current growth trajectory should continue into FY25-26
BUSINESS
What does Advent Group’s equity infusion mean for Apollo Hospital stock?
After the integration of Keimed with AHL, Advent will hold a 12.1% stake in the combined entity.
BUSINESS
Has Sharda Cropchem managed to tide over all the challenges?
Concern around business outlook lingers as international markets may take time to recover
BUSINESS
Max Healthcare: A healthy but pricey stock
The healthcare company’s medium-term revenue growth visibility appears healthy
BUSINESS
Medanta: Charting a growth path
Medanta has strong capabilities to leverage its brand image and win the underserved and growing markets.
BUSINESS
KIMS: Why are we turning optimistic on this healthcare stock?
KIMS is well-positioned to seize the growing demand for healthcare facilities in the country. Timely execution and ramp-up of new projects will be crucial
BUSINESS
Rainbow Children’s Medicare: New hospitals act as the growth tonic
The company is best placed to benefit from the synergies between paediatric and OB-GYN segments
BUSINESS
Fertiliser stocks: Why a normal monsoon may not bring all the cheer
Much will depend on subsidy rates as raw material prices are rising
BUSINESS
Krsnaa Diagnostics: Expanding addressable market with a B2C foray
With the ramp-up of new projects, the current revenue growth trajectory should continue into FY25-26
BUSINESS
Apollo Hospitals: Strong Q1 FY25, growth momentum to continue
AHEL expansion plans are on track to add about 1,890 beds by FY26
BUSINESS
NMDC Q1 FY25: Strong profit growth unlikely to stage a repeat show
The company has reduced prices for iron ore lumps and fines by 10 percent each
BUSINESS
Hindalco reports in-line Q1 numbers, outlook remains moderate
Top-line growth was muted; EBITDA improved marginally
BUSINESS
PI Industries: Strong Q1FY25, but growth momentum slows
The company has reiterated about 15% top-line growth and 25-26% EBITDA margin in FY25.
